David J. Harrison

23.8k total citations · 3 hit papers
482 papers, 17.6k citations indexed

About

David J. Harrison is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David J. Harrison has authored 482 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Molecular Biology, 115 papers in Oncology and 58 papers in Cancer Research. Recurrent topics in David J. Harrison's work include Cancer Genomics and Diagnostics (37 papers), Cancer-related Molecular Pathways (32 papers) and Epigenetics and DNA Methylation (27 papers). David J. Harrison is often cited by papers focused on Cancer Genomics and Diagnostics (37 papers), Cancer-related Molecular Pathways (32 papers) and Epigenetics and DNA Methylation (27 papers). David J. Harrison collaborates with scholars based in United Kingdom, United States and Netherlands. David J. Harrison's co-authors include Alan R. Clarke, M.L. Hooper, Colin A. Purdie, A H Wyllie, Russell E. Morris, C C Bird, Simon P. Langdon, Christopher A. Smith, John D. Hayes and Dana Faratian and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David J. Harrison

460 papers receiving 17.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thymocyte apoptosis induced by p53-dependent and independent pathways

1993 2.0k citations David J. Harrison, A H Wyllie et al. profile →
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

1999 511 citations David J. Harrison et al. profile →
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system

2015 455 citations Simon P. Langdon, In Hwa Um et al. Scientific Reports profile →

Peers

Countries citing papers authored by David J. Harrison

Since Specialization

Citations

This map shows the geographic impact of David J. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Harrison more than expected).

Fields of papers citing papers by David J. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Harrison. The network helps show where David J. Harrison may publish in the future.

Co-authorship network of co-authors of David J. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Harrison. A scholar is included among the top collaborators of David J. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Harrison. David J. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved Nucleoside (2′-Deoxy)Ribosyltransferases Maximize Enzyme Promiscuity while Maintaining Catalytic Efficiency 2025 ·ACS Chemical Biology ·Peijun Tang, (unknown), (unknown), Christopher J. Harding, (unknown), Tomáš Lébl, David J. Harrison, Rafael G. da Silva, Clarissa Melo Czekster	0
2	Determining the Impact of Histology on the Incidence, Pattern, and Timing of Recurrences in Patients with Renal Cell Carcinoma: A Pooled Analysis from the SORCE and ASSURE Trials 2025 ·European Urology Open Science ·Bhavna Oza, Eleni Frangou, Tim Eisen, Grant D. Stewart, Axel Bex, David J. Harrison, Mahesh Parmar, Ruth E. Langley, Duncan C. Gilbert, Angela Meade	0
3	Magnifying Networks for Histopathological Images with Billions of Pixels 2024 ·Diagnostics ·(unknown), Ognjen Arandjelović, David J. Harrison	1
4	Kisspeptin is elevated in the brain after intracerebral haemorrhagic stroke 2024 ·Scientific Reports ·(unknown), In Hwa Um, (unknown), (unknown), Karina McDade, Tracey Millar, David J. Harrison, Javier A. Tello	2
5	The Eucharist Online: Learning from Communications Theory 2023 ·Consensus ·David J. Harrison	1
6	MultiPathGAN: Structure Preserving Stain Normalization using Unsupervised Multi-domain Adversarial Network with Perception Loss 2023 ·(unknown), Ognjen Arandjelović, In Hwa Um, David J. Harrison	8
7	Whole-Slide Images and Patches of Clear Cell Renal Cell Carcinoma Tissue Sections Counterstained with Hoechst 33342, CD3, and CD8 Using Multiple Immunofluorescence 2023 ·Data ·Georg Wölflein, In Hwa Um, David J. Harrison, Ognjen Arandjelović	1
8	Lymphocyte Classification from Hoechst Stained Slides with Deep Learning 2022 ·Cancers ·Jessica Cooper, In Hwa Um, Ognjen Arandjelović, David J. Harrison	3
9	Use of High-Plex Data Reveals Novel Insights into the Tumour Microenvironment of Clear Cell Renal Cell Carcinoma 2022 ·Cancers ·(unknown), Georg Wölflein, In Hwa Um, Peter D. Caie, Sarah Warren, Andrew White, (unknown), (unknown), Ognjen Arandjelović, David J. Harrison	7
10	Exploring Perceptions of a Fresh Food Prescription Program during COVID-19 2022 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David J. Harrison, Kimberly Móntez	7
11	A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer 2021 ·Clinical Cancer Research ·Farasat Kazmi, Shibani Nicum, René L. Roux, Laura Spiers, (unknown), (unknown), Hani Gabra, Essam Ghazaly, Nigel McCracken, David J. Harrison, Sarah P. Blagden	4
12	Assessment of Immunological Features in Muscle-Invasive Bladder Cancer Prognosis Using Ensemble Learning 2021 ·Cancers ·(unknown), (unknown), Nicolas Brieu, Ines P. Nearchou, Ognjen Arandjelović, Günter Schmidt, David J. Harrison, Peter D. Caie	19
13	Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer 2019 ·Cancer Immunology Research ·Ines P. Nearchou, Kate Lillard, (unknown), Hideki Ueno, David J. Harrison, Peter D. Caie	68
14	Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer 2015 ·Clinical Cancer Research ·Grant D. Stewart, Fiach C. O’Mahony, Alexander Laird, Lél Eöry, (unknown), Alan Mackay, Jyoti Nanda, Marie O’Donnell, Peter Mullen, S. Alan McNeill, Antony C. P. Riddick, Daniel M. Berney, Axel Bex, Michael Aitchison, Ian M. Overton, David J. Harrison, Thomas Powles	29
15	Design for Sustainable Behaviour: Proposing a new eco-feedback device based on augmented reality technology 2013 ·Northumbria Research Link (Northumbria University) ·(unknown), David J. Harrison, Shengfeng Qin	3
16	Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells 2010 ·Cancer Research ·Falko Hochgräfe, Luxi Zhang, Sandra O’Toole, Brigid C. Browne, Mark Pinese, (unknown), Gillian M. Lehrbach, David R. Croucher, Danny Rickwood, Alice Boulghourjian, Robert F. Shearer, Radhika Nair, Alexander Swarbrick, Dana Faratian, Peter Mullen, David J. Harrison, Andrew V. Biankin, Robert L. Sutherland, Mark J. Raftery, Roger J. Daly	141
17	Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab 2009 ·Cancer Research ·Dana Faratian, Alexey Goltsov, (unknown), Anatoly Sorokin, Stuart Moodie, Peter Mullen, Charlene Kay, In Hwa Um, Simon P. Langdon, Igor Goryanin, David J. Harrison	126
18	WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin α3 2009 ·Cancer Research ·Charlie Gourley, Adam J.W. Paige, Karen J. Taylor, (unknown), (unknown), Jieqing Zhang, Mingjun Sun, Szymon Janczar, David J. Harrison, Morwenna Muir, John F. Smyth, Hani Gabra	84
19	c‐Myc partially mediates IFNγ‐induced apoptosis in the primary hepatocyte 2007 ·International Journal of Experimental Pathology ·(unknown), (unknown), David J. Harrison	4
20	N -acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions 1997 ·Gut ·(unknown), David J. Harrison, Catherine L. Moyes, A H Wyllie, C Cunningham, (unknown), Colin Smith	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact